These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37599567)

  • 1. Clinicopathological Impacts of Expression of Neuronal Markers in Lymphangioleiomyomatosis.
    Kishi M; Hayashi T; Mitani K; Tsuboshima K; Kurihara M; Hosoya M; Sekimoto Y; Okura MK; Mitsuishi Y; Okada Y; Kanno J; Yao T; Takahashi K; Seyama K
    Am J Surg Pathol; 2023 Nov; 47(11):1252-1260. PubMed ID: 37599567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis.
    Delaney SP; Julian LM; Stanford WL
    Front Cell Dev Biol; 2014; 2():69. PubMed ID: 25505789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small airways morphological alterations associated with functional impairment in lymphangioleiomyomatosis.
    Mendonça LP; Costa NSX; do Nascimento ECT; de Oliveira MR; de Carvalho CRR; Baldi BG; Dolhnikoff M
    BMC Pulm Med; 2024 Jan; 24(1):22. PubMed ID: 38195527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
    Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
    PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphangioleiomyomatosis Association with Underlying Genotype in Patients with Tuberous Sclerosis Complex.
    Tian X; Glass JE; Kwiatkowski DJ; Towbin AJ; Li Y; Sund KL; Krueger DA; Franz DN; McCormack FX; Gupta N
    Ann Am Thorac Soc; 2021 May; 18(5):815-819. PubMed ID: 33171065
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural history of incidental sporadic and tuberous sclerosis complex associated lymphangioleiomyomatosis.
    Di Marco F; Terraneo S; Dias OM; Imeri G; Centanni S; Rinaldo RF; Giuliani L; Lesma E; Palumbo G; Wanderley M; Ribeiro Carvalho CR; Guedes Baldi B
    Respir Med; 2020 Jul; 168():105993. PubMed ID: 32469709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental Pelvic and Para-aortic Lymph Node Lymphangioleiomyomatosis Detected During Surgical Staging of Pelvic Cancer in Women Without Symptomatic Pulmonary Lymphangioleiomyomatosis or Tuberous Sclerosis Complex.
    Rabban JT; Firetag B; Sangoi AR; Post MD; Zaloudek CJ
    Am J Surg Pathol; 2015 Aug; 39(8):1015-25. PubMed ID: 25786086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evaluation of pulmonary lymphangioleiomyomatosis.
    Grzegorek I; Lenze D; Chabowski M; Janczak D; Szolkowska M; Langfort R; Szuba A; Dziegiel P
    Anticancer Res; 2015 Jun; 35(6):3353-60. PubMed ID: 26026095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selected case from the Arkadi M. Rywlin International Pathology Slide Seminar: Sporadic lymphangioleiomyomatosis.
    Bisceglia M; D'Alessandro V; Simeone A; Ben-Dor D; Pasquinelli G
    Adv Anat Pathol; 2010 Nov; 17(6):445-52. PubMed ID: 20966650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in Japanese patients with tuberous sclerosis complex.
    Tanaka M; Hirata H; Wataya-Kaneda M; Yoshida M; Katayama I
    Respir Investig; 2016 Jan; 54(1):8-13. PubMed ID: 26718139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis.
    Smolarek TA; Wessner LL; McCormack FX; Mylet JC; Menon AG; Henske EP
    Am J Hum Genet; 1998 Apr; 62(4):810-5. PubMed ID: 9529362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase-type plasminogen activator (uPA) is critical for progression of tuberous sclerosis complex 2 (TSC2)-deficient tumors.
    Stepanova V; Dergilev KV; Holman KR; Parfyonova YV; Tsokolaeva ZI; Teter M; Atochina-Vasserman EN; Volgina A; Zaitsev SV; Lewis SP; Zabozlaev FG; Obraztsova K; Krymskaya VP; Cines DB
    J Biol Chem; 2017 Dec; 292(50):20528-20543. PubMed ID: 28972182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sporadic lymphangioleiomyomatosis and tuberous sclerosis complex with lymphangioleiomyomatosis: comparison of CT features.
    Avila NA; Dwyer AJ; Rabel A; Moss J
    Radiology; 2007 Jan; 242(1):277-85. PubMed ID: 17105849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberous Sclerosis Complex: State-of-the-Art Review with a Focus on Pulmonary Involvement.
    von Ranke FM; Zanetti G; e Silva JL; Araujo Neto CA; Godoy MC; Souza CA; Mançano AD; Souza AS; Escuissato DL; Hochhegger B; Marchiori E
    Lung; 2015 Oct; 193(5):619-27. PubMed ID: 26104489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 is induced by rapamycin in a model of tuberous sclerosis (TSC) and lymphangioleiomyomatosis (LAM).
    Trindade AJ; Medvetz DA; Neuman NA; Myachina F; Yu J; Priolo C; Henske EP
    PLoS One; 2013; 8(3):e60014. PubMed ID: 23555865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for Lymphangioleiomyomatosis and Tuberous Sclerosis: Progress and Future Directions.
    Liu HJ; Krymskaya VP; Henske EP
    Chest; 2019 Dec; 156(6):1062-1067. PubMed ID: 31437431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapulmonary lymphangioleiomyomatosis and lymphangiomatous cysts in tuberous sclerosis complex.
    Torres VE; Björnsson J; King BF; Kumar R; Zincke H; Edell ES; Wilson TO; Hattery RR; Gomez MR
    Mayo Clin Proc; 1995 Jul; 70(7):641-8. PubMed ID: 7791386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of angiomyolipoma in lymphangioleiomyomatosis: implications for screening and surveillance.
    Yeoh ZW; Navaratnam V; Bhatt R; McCafferty I; Hubbard RB; Johnson SR
    Orphanet J Rare Dis; 2014 Oct; 9():151. PubMed ID: 25277108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [IMPORTANCE OF SCREENING FOR LUNG LYMPHANGIOLEIOMYOMATOSIS AMONG RENAL ANGIOMYOLIPOMA CASES].
    Sakaguchi K; Oka S; Ogawa K; Nagamoto S; Kurosawa K; Urakami S; Okaneya T
    Nihon Hinyokika Gakkai Zasshi; 2017; 108(4):188-193. PubMed ID: 30333440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and histopathological alterations of lymphangioleiomyomatosis in 14 Chinese patients.
    Lu SH; Hou YY; Tan YS; Xu JF; Zeng HY; Sujie AK; Wang XD; Bai CX
    Chin Med J (Engl); 2009 Aug; 122(16):1895-900. PubMed ID: 19781367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.